Trials / Completed
CompletedNCT01193179
A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes
Long-term Co-administration Study of OPC-262 in Patients With Type 2 Diabetes Mellitus
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 450 (estimated)
- Sponsor
- Kyowa Kirin Co., Ltd. · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the safety of OPC-262 administered orally in combination with another oral antihyperglycemic agent
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | OPC-262 | Oral administration of tablets for 52 weeks |
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2012-04-01
- Completion
- 2012-04-01
- First posted
- 2010-09-01
- Last updated
- 2014-01-08
Locations
4 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT01193179. Inclusion in this directory is not an endorsement.